Table 1. Baseline characteristics of the 198 patients and QUALID scores of various subgroups of the patients.
Baseline characteristics | p-value | ||
Gender | Men (n = 42) | 20.1 (6.5) | .592a |
Women (n = 156) | 20.8 (7.1) | ||
Age, years | <79 (n = 30) | 23.2 (6.9) | .137b |
80–84 (n = 30) | 19.5 (5.4) | ||
85–89 (n = 55) | 20.1 (7.1) | ||
90+ (n = 83) | 20.5 (7.3) | ||
General medical health | Good (n = 31) | 18.6 (6.3) | .034b |
Fair (n = 101) | 19.9 (6.2) | ||
Poor (n = 53) | 22.5 (8.2) | ||
Very poor (n = 13) | 23.4 (7.0) | ||
Type of dementia | Alzheimer's dementia (n = 94) | 21.3 (7.4) | .244a |
Other dementias (n = 104) | 20.0 (6.5) | ||
CDR score | 1 (n = 49) | 18.6 (6.3) | .000b |
2 (n = 73) | 19.0 (6.0) | ||
3(n = 76) | 23.6 (7.4) | ||
PSMS score | 6–13 (n = 54) | 17.9 (5.1) | .000b |
14–17 (n = 41) | 19.1 (5.9) | ||
18–21 (n = 53) | 21.6 (7.1) | ||
22–30 (n = 50) | 23.8 (8.1) | ||
NPI-Q-10 number of symptoms | 0–1 symptoms (n = 69) | 16.3 (5.0) | .000b |
2–3 symptoms (n = 71) | 20.9 (6.2) | ||
4–9 symptoms (n = 58) | 25.5 (6.8) | ||
Number of psychotropic drugs on daily basis | 0–2 n = 185 | 20.5 (6.9) | .567a |
3–9 n = 13 | 22.2 (8.6) | ||
Sedatives | No (n = 165) | 20.6 (7.0) | .856a |
Yes (n = 33) | 20.8 (7.0) | ||
Antipsychotics | No (n = 169) | 20.2 (6.8) | .027a |
Yes (n = 29) | 23.4 (7.6) | ||
Anxiolytics | No (n = 165) | 20.3 (6.9) | .059a |
Yes (n = 33) | 22.5 (7.0) | ||
Antidepressants | No (n = 134) | 20.7 (6.8) | .608a |
Yes (n = 64) | 20.5 (7.5) | ||
Antidementia | No (n = 182) | 20.8 (7.0) | .130a |
Yes (n = 16) | 18.3 (5.9) | ||
Type of ward | RU (n = 118) | 20.3 (7.4) | .140a |
SCU (n = 80) | 21.2 (6.3) | ||
Time in ward | < = 6 months (n = 35) | 18.5 (5.7) | .059a |
>6 months (n = 163) | 21.1 (7.2) |
Mann-Whitney U-test, bKruskal-Wallis test, CDR = Clinical Dementia Rating, PSMS = Physical Self Maintenance Scale, NPI-Q-10 = Neuropsychiatric Inventory Questionnaire, 10 items, RU = regular unit, SCU = special care unit.